View in EDS HTML Full Text PDF Full Text

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.

Saved in:
Bibliographic Details
Title: A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.
Authors: Rostad CA; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Atmar RL; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Walter EB; Department of Pediatrics and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA., Frey S; Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA., Meier JL; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Sherman AC; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Lai L; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Tsong R; Emmes, Inc., Rockville, Maryland, USA., Kao CM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Raabe V; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; New York University Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA., El Sahly HM; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Keitel WA; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Whitaker JA; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Smith MJ; Department of Pediatrics and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA., Schmader KE; Department of Medicine-Geriatrics, Duke University and GRECC, Durham VA Health Care System, Durham, North Carolina, USA., Swamy GK; Department of Obstetrics and Gynecology and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA., Abate G; Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA., Winokur P; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Buchanan W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Cross K; Emmes, Inc., Rockville, Maryland, USA., Wegel A; Emmes, Inc., Rockville, Maryland, USA., Xu Y; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Rouphael N; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Mulligan MJ; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; New York University Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1757-1768.
Publication Type: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38537255
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rostad+CA%22">Rostad CA</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Atmar+RL%22">Atmar RL</searchLink>; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Walter+EB%22">Walter EB</searchLink>; Department of Pediatrics and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Frey+S%22">Frey S</searchLink>; Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Meier+JL%22">Meier JL</searchLink>; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Sherman+AC%22">Sherman AC</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Lai+L%22">Lai L</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Tsong+R%22">Tsong R</searchLink>; Emmes, Inc., Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kao+CM%22">Kao CM</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Raabe+V%22">Raabe V</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; New York University Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22El+Sahly+HM%22">El Sahly HM</searchLink>; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Keitel+WA%22">Keitel WA</searchLink>; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Whitaker+JA%22">Whitaker JA</searchLink>; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Smith+MJ%22">Smith MJ</searchLink>; Department of Pediatrics and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Schmader+KE%22">Schmader KE</searchLink>; Department of Medicine-Geriatrics, Duke University and GRECC, Durham VA Health Care System, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Swamy+GK%22">Swamy GK</searchLink>; Department of Obstetrics and Gynecology and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Abate+G%22">Abate G</searchLink>; Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Winokur+P%22">Winokur P</searchLink>; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.<br /><searchLink fieldCode="AU" term="%22Buchanan+W%22">Buchanan W</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Cross+K%22">Cross K</searchLink>; Emmes, Inc., Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wegel+A%22">Wegel A</searchLink>; Emmes, Inc., Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Yildirim+I%22">Yildirim I</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Kamidani+S%22">Kamidani S</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Rouphael+N%22">Rouphael N</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Roberts+PC%22">Roberts PC</searchLink>; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Mulligan+MJ%22">Mulligan MJ</searchLink>; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; New York University Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+EJ%22">Anderson EJ</searchLink>; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1757-1768.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38537255
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cid/ciae173
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1757
    Titles:
      – TitleFull: A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rostad CA
      – PersonEntity:
          Name:
            NameFull: Atmar RL
      – PersonEntity:
          Name:
            NameFull: Walter EB
      – PersonEntity:
          Name:
            NameFull: Frey S
      – PersonEntity:
          Name:
            NameFull: Meier JL
      – PersonEntity:
          Name:
            NameFull: Sherman AC
      – PersonEntity:
          Name:
            NameFull: Lai L
      – PersonEntity:
          Name:
            NameFull: Tsong R
      – PersonEntity:
          Name:
            NameFull: Kao CM
      – PersonEntity:
          Name:
            NameFull: Raabe V
      – PersonEntity:
          Name:
            NameFull: El Sahly HM
      – PersonEntity:
          Name:
            NameFull: Keitel WA
      – PersonEntity:
          Name:
            NameFull: Whitaker JA
      – PersonEntity:
          Name:
            NameFull: Smith MJ
      – PersonEntity:
          Name:
            NameFull: Schmader KE
      – PersonEntity:
          Name:
            NameFull: Swamy GK
      – PersonEntity:
          Name:
            NameFull: Abate G
      – PersonEntity:
          Name:
            NameFull: Winokur P
      – PersonEntity:
          Name:
            NameFull: Buchanan W
      – PersonEntity:
          Name:
            NameFull: Cross K
      – PersonEntity:
          Name:
            NameFull: Wegel A
      – PersonEntity:
          Name:
            NameFull: Xu Y
      – PersonEntity:
          Name:
            NameFull: Yildirim I
      – PersonEntity:
          Name:
            NameFull: Kamidani S
      – PersonEntity:
          Name:
            NameFull: Rouphael N
      – PersonEntity:
          Name:
            NameFull: Roberts PC
      – PersonEntity:
          Name:
            NameFull: Mulligan MJ
      – PersonEntity:
          Name:
            NameFull: Anderson EJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 06
              Text: 2024 Jun 14
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6591
          Numbering:
            – Type: volume
              Value: 78
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
              Type: main
ResultId 1